Metraipolis › archive › dc_5941ef4696d3

[Disease-modifying therapy with lecanemab for early Alzheimer's dementia] — Europe PMC PMID:41052542

Source
Europe PMC (de)
Original
https://europepmc.org/article/MED/41052542
DOI
10.1055/a-2681-4558
License (as archived)
solo-consultazione
Archived
2026-11-09T13:08:09.522Z
SHA-256 of the archived text
390cd419375f8d69c2c7706fc06180eea57b129e2fbfb303fc280e5937b05d90
Stable URL of this page
https://metraipolis.com/documento/dc_5941ef4696d3

How to cite

[Disease-modifying therapy with lecanemab for early Alzheimer's dementia] — Europe PMC PMID:41052542 — Europe PMC (de), https://europepmc.org/article/MED/41052542 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5941ef4696d3 (Metraipolis archive dc_5941ef4696d3, sha256 390cd419375f8d69c2c7706fc06180eea57b129e2fbfb303fc280e5937b05d90)
BibTeX
@misc{dc5941ef4696d3,
  title = {[Disease-modifying therapy with lecanemab for early Alzheimer's dementia] — Europe PMC PMID:41052542},
  howpublished = {Europe PMC (de)},
  url = {https://europepmc.org/article/MED/41052542},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5941ef4696d3; sha256 390cd419375f8d69c2c7706fc06180eea57b129e2fbfb303fc280e5937b05d90},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41052542. Agents can read the archived copy with the MCP tool read_document.